Impact of AHCC® Supplementation for Prevention of Respiratory Tract Infections Among Children Age 4-6 Years Old

Starting soon · Phase 4 · Has a placebo group

Conditions studied: Respiratory Tract Infections (RTI)

In brief

This is a study to evaluate the effects of a prebiotic, AHCC, a standardized extract of cultured Lentinula edodes mycelia, on immunologic markers and the incidence of respiratory tract infections in children.

Key facts

Study ID

NCT07479394

Run by

Hasanuddin University

People needed

60

Starts

2026-08-15

Expected to finish

2027-02-28

Last updated by the study team

2026-07-10

Who can join

Age: 4 and older, up to 6. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Children aged 4-6 years old at the time of enrolment
• Good nutritional status with weight-for-height > -2, and height-for-age z-score > -2 based on WHO growth standards
• Infants in a group setting (daycare centers).
• No congenital disorder
• Not suffering from severe coughing or diarrhoea at the time of recruitment
• Written informed consent will be obtained from parents or legal guardians before enrollment.

You may not qualify if…

• Presence of chronic illnesses or conditions (congenital disorder, genetic syndromes, congenital heart disease, chronic renal failure, cystic fibrosis, etc)
• Children who have participated in another clinical intervention study within the past 30 days.
• Children who are likely to be transferred to another facility that is not part of the study before completing the follow-up period

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.